文献速递免疫规划卫生政策与健康促进

纳米贴片微针阵列儿童免疫接种终端用户可接受性研究

End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countries.
PubMed 文献 · Vaccine · 2019-03-16

该研究在贝宁、尼泊尔和越南评估纳米贴片(一种固体微针阵列装置)用于儿童疫苗接种的预期可接受性,共314人参与,采用儿童接种模拟和关键利益相关者深度访谈等方法。总体可接受率为92.7%,参与者普遍持积极态度,但前提是临床研究证实微针阵列贴片接种无痛、安全且有效。研究建议先由熟练医护人员在医疗机构推广,之后可在其监督下由选定志愿者和外展服务实施接种。

要点

  • 纳米贴片用于儿童免疫的总体可接受率为92.7%(314名参与者)。
  • 可接受性以临床研究证实接种无痛、安全有效为前提。
  • 推广策略首选熟练医护人员在医疗机构接种,后续可扩展至志愿者外展。

核心结论

  • 纳米贴片用于儿童免疫接种在贝宁、尼泊尔和越南的预期总体可接受率为92.7%。
  • 参与者普遍持积极态度,但以临床研究证实微针阵列贴片接种无痛、安全且有效为条件。

研究设计与样本

  • 研究在贝宁、尼泊尔和越南开展,共314人参与,非真实场景评估研究。
  • 采用儿童接种模拟和关键利益相关者、医护人员、社区卫生志愿者、看护者及社区代表深度访谈等多种评估方法。

主要发现

  • 纳米贴片用于儿童免疫的总体可接受率为92.7%。
  • 参与者总体意见非常积极,前提是临床研究证实微针阵列贴片接种无痛、安全且有效。

关键数值与推荐

  • 总体可接受率为92.7%(314名参与者)。
  • 推广策略首选由熟练医护人员在医疗机构接种以确立该技术。
  • 此后可在熟练医护人员监督下由选定志愿者和外展服务实施接种。

临床怎么用

  • 推广纳米贴片接种应优先在医疗机构由熟练医护人员实施,以建立技术基础。
  • 后续可考虑在熟练医护人员监督下由选定志愿者和外展服务提供接种。

局限性

  • 本研究非真实场景评估研究,仅评估预期可接受性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A promising new delivery technology, the microarray patch (MAPs) consists of an array of small solid-coated or dissolvable needles, up to one mm in length, that administers a dry formulation of a vaccine or pharmaceutical. This study is not a real-life evaluation study but determines the anticipated acceptability of the Nanopatch™, a solid microarray patch device, in Benin, Nepal and Vietnam for vaccine delivery, and identifies factors that could improve the acceptability of the technology to increase measles immunization coverage. This study combined several evaluation methods, including simulation of vaccine administration on children and in-depth interviews with key stakeholders, healthcare workers, community health volunteers, caretakers, and community representatives. A total of 314 people participated in the study. The overall rate of total acceptability of the patch for child immunization was 92.7%. General opinions were very positive, providing clinical studies confirm that MAP administration is demonstrated to be painless, safe and effective for infectious disease prevention. The study participants were asked to consider the best strategy to introduce such vaccine delivery innovation. Firstly, delivery by skilled healthcare workers at the healthcare facilities will be preferred to establish the technology. Following this, administration by selected volunteers and outreach delivery may be possible, though under the supervision of skilled healthcare workers. This study's protocol received approval from the World Health Organization (WHO) Ethical Research Committee (ERC0002813) and the national IRB in Benin, Nepal and Vietnam.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Guillermet E, Alfa DA, Phuong Mai LT, et al. End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countries. Vaccine. 2019. PMID: 30890383. doi:10.1016/j.vaccine.2019.02.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。